Shopping Cart
Remove All
Your shopping cart is currently empty
Etofylline clofibrate has a hypolipidemic and antithrombotic effect and it also has an agonistic interaction with intimal PGI2.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $48 | 5 days | 5 days | |
| 5 mg | $76 | 5 days | 5 days | |
| 1 mL x 10 mM (in DMSO) | $107 | 5 days | 5 days |
| Description | Etofylline clofibrate has a hypolipidemic and antithrombotic effect and it also has an agonistic interaction with intimal PGI2. |
| In vivo | Etofylline clofibrate administered orally at a dosage of 12 mg/kg demonstrates a moderate initial efficacy with a 12% reduction in disaggregation time from a single dose. The effectiveness of the compound increases significantly with consistent daily usage, achieving a maximum reduction in disaggregation time of 31% after 5 days and 43% after 7 days of consecutive applications. |
| Molecular Weight | 420.85 |
| Formula | C19H21ClN4O5 |
| Cas No. | 54504-70-0 |
| Relative Density. | 1.37g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 52 mg/mL (123.56 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 2.5 mg/mL (5.94 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.